The DOI matches its Crossref record.
Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat
Abstract
Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear hormone receptor superfamily that can be activated by various xenobiotics and natural fatty acids. These transcription factors primarily regulate genes involved in lipid metabolism and also play a role in adipocyte differentiation. We present the expression patterns of the PPAR subtypes in the adult rat, determined by in situ hybridization using specific probes for PPAR-alpha, -beta and -gamma, and by immunohistochemistry using a polyclonal antibody that recognizes the three rat PPAR subtypes. In numerous cell types from either ectodermal, mesodermal, or endodermal origin, PPARs are coexpressed, with relative levels varying between them from one cell type to the other. PPAR-alpha is highly expressed in hepatocytes, cardiomyocytes, enterocytes, and the proximal tubule cells of kidney. PPAR-beta is expressed ubiquitously and often at higher levels than PPAR-alpha and -gamma. PPAR-gamma is expressed predominantly in adipose tissue and the immune system. Our results suggest new potential directions to investigate the functions of the different PPAR subtypes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, PPAR-γ is commonly expressed in macrophages and yields anti-inflammatory effects in liver fibrosis.[105]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [105]
Citations
Cited by
Sorted by citations
Items 101–200 of 1,005
Doull, J., Cattley, R. C., Elcombe, C. R., Lake, B. G., Swenberg, J. A., Wilkinson, C., Williams, G. M., & van Gemert, M. (1999) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1999.1296 · Cited by 337
Barberà, M. J., Schlüter, A., Pedraza, N., Iglesias, R., Villarroya, F., & Giralt, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006246200 · Cited by 344
The role of PPARs in inflammation and immunity
Clark, R. B. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.3.388 · Cited by 337
Phthalates: European regulation, chemistry, pharmacokinetic and related toxicity
Ventrice, P., Ventrice, D., Russo, E., & De Sarro, G. (2013) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2013.03.014 · Cited by 333
Cardiomyocyte expression of PPARγ leads to cardiac dysfunction in mice
Son, N.-H., Park, T., Yamashita, H., Yokoyama, M., Huggins, L. A., Okajima, K., Homma, S., Szabolcs, M. J., Huang, L., & Goldberg, I. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30335 · Cited by 340
Groh, K. J., Pakdel, F., Segner, H. E., Kah, O., & Eggen, R. I. L. (2007) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2007.03.005 · Cited by 345
Yoon, M. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.02.004 · Cited by 336
Troglitazone action is independent of adipose tissue.
Burant, C., Sreenan, S., Hirano, K., Tai, T. A., Lohmiller, J. J., Lukens, J. N., Davidson, N. O., Ross, S. R., & Graves, R. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119839 · Cited by 331
Zhang, B., Berger, J., Hu, E., Szalkowski, D., White-Carrington, S., Spiegelman, B. M., & Moller, D. E. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.11.8923470 · Cited by 328
Sharma, P., Srivastava, P., Seth, A., Tripathi, P. N., Banerjee, A. G., & Shrivastava, S. K. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.006 · Cited by 331
Petrosino, S., & Marzo, V. D. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13580 · Cited by 340
Metabolomics Applied to Diabetes Research
Bain, J. R., Stevens, R. D., Wenner, B. R., Ilkayeva, O., Muoio, D. M., & Newgard, C. B. (2009) · Diabetes · doi:10.2337/db09-0580 · Cited by 336
PPARγ: a circadian transcription factor in adipogenesis and osteogenesis
Kawai, M., & Rosen, C. J. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.155 · Cited by 328
Abnormal spermatogenesis in RXR beta mutant mice.Preprint
Kastner, P., Mark, M. P., Leid, M. E., Gansmüller, A., Chin, W. W., Grondona, J. M., Décimo, D., Krężel, W., Dierich, A., & Chambon, P. (1996) · Genes & Development · doi:10.1101/gad.10.1.80 · Cited by 328
Cardiac fatty acid uptake and transport in health and disease
Vusse, G. J. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00263-1 · Cited by 318
Watanabe, K., Fujii, H., Takahashi, T., Kodama, M., Aizawa, Y., Ohta, Y., Ono, T., Hasegawa, G., Naito, M., Nakajima, T., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000248200 · Cited by 314
HENEKA, M., & LANDRETH, G. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.04.016 · Cited by 317
Zhang, H., Zhang, A., Kohan, D. E., Nelson, R. D., Gonzalez, F. J., & Yang, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501744102 · Cited by 314
Tsubouchi, Y., Sano, H., Kawahito, Y., Mukai, S., Yamada, R., Kohno, M., Inoue, K., Hla, T., & Kondo, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2436 · Cited by 312
Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors
Francque, S., Szabo, G., Abdelmalek, M. F., Byrne, C. D., Cusi, K., Dufour, J.-F., Roden, M., Sacks, F., & Tacke, F. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00366-5 · Cited by 316
Cloning, Expression, and Pharmacological Characterization of a Novel Human Histamine Receptor
Zhu, Y., Michalovich, D., Wu, H.-L., Tan, K. B., Dytko, G. M., Mannan, I. J., Boyce, R. W., Alston, J. T., Tierney, L. A., Li, X., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.3.434 · Cited by 312
PPARs: transcriptional effectors of fatty acids and their derivatives
Hihi, A. K., Michalik, L., & Wahli, W. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8467-x · Cited by 310
Self-citationMir193b–365 is essential for brown fat differentiation
Sun, L., Xie, H., Mori, M. A., Alexander, R., Yuan, B., Hattangadi, S. M., Liu, Q., Kahn, C. R., & Lodish, H. F. (2011) · Nature Cell Biology · doi:10.1038/ncb2286 · Cited by 313
Comparative Analysis of Gene Regulation by the Transcription Factor PPARα between Mouse and Human
Rakhshandehroo, M., Hooiveld, G. J. E. J., Müller, M. M., & Kersten, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006796 · Cited by 317
Shi, Y., Hon, M., & Evans, R. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052707099 · Cited by 305
Ricote, M., Huang, J. T., Welch, J. S., & Glass, C. K. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.5.733 · Cited by 306
Memon, R. A., Tecott, L. H., Nonogaki, K., Beigneux, A. P., Moser, A. H., Grünfeld, C., & Feingold, K. R. (2000) · Endocrinology · doi:10.1210/endo.141.11.7771 · Cited by 302
Skin abnormalities generated by temporally controlled RXRα mutations in mouse epidermis
Li, M., Indra, A. K., Warot, X. M., Brocard, J., Messaddeq, N., Kato, S., METZGER, D., & Chambon, P. (2000) · Nature · doi:10.1038/35036595 · Cited by 301
Braissant, O., & Wahli, W. (1998) · Cited by 299
Self-citationYoshikawa, T., Ide, T., Shimano, H., Yahagi, N., Amemiya-Kudo, M., Matsuzaka, T., Yatoh, S., Kitamine, T., Okazaki, H., Tamura, Y., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0190 · Cited by 306
Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease
Guan, Y., & Breyer, M. D. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00766.x · Cited by 292
Regulation of Lipid and Lipoprotein Metabolism by PPAR Activators
Gervois, P., Torra, I. P., Fruchart, J.-C., & Staels, B. (2000) · cclm · doi:10.1515/cclm.2000.002 · Cited by 249
Chen, W., Dong, J., Plate, L., Mortenson, D. E., Brighty, G. J., Li, S., Liu, Y., Galmozzi, A., Lee, P. S., Hulce, J. J., et al. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b02960 · Cited by 294
Savoia, C., & Schiffrin, E. L. (2006) · Current Opinion in Internal Medicine · doi:10.1097/01.mnh.0000203189.57513.76 · Cited by 287
Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome
Leo, V. D., Marca, A. L., & Petraglia, F. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0015 · Cited by 291
Gremlich, S., Bonny, C., Waeber, G., & Thorens, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30261 · Cited by 276
PPARγ and the Treatment of Insulin Resistance
Olefsky, J. M., & Saltiel, A. R. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00306-4 · Cited by 280
Role of Orphan Nuclear Receptors in the Regulation of Drug-Metabolising Enzymes
Wang, H., & LeCluyse, E. L. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342150-00003 · Cited by 284
Kuroda, K., Han, H., Tani, S., Tanigaki, K., Tun, T., Furukawa, T., Taniguchi, Y., Kurooka, H., Hamada, Y., Toyokuni, S., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00029-3 · Cited by 286
Aging and dyslipidemia: A review of potential mechanisms
Liu, H., & Li, J. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.12.001 · Cited by 279
Regulation of translocator protein 18kDa (TSPO) expression in health and disease states☆
Batarseh, A. M., & Papadopoulos, V. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.06.013 · Cited by 286
van Raalte, D. H., Li, M., Pritchard, P. H., & Wasan, K. M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000041444.06122.8d · Cited by 270
Heneka, M. T., Klockgether, T., & Feinstein, D. L. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-18-06862.2000 · Cited by 269
Ren, B., Thelen, A. P., Peters, J. M., Gonzalez, F. J., & Jump, D. Β. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.26827 · Cited by 264
The Function of TIF2/GRIP1 in Mouse Reproduction Is Distinct from Those of SRC-1 and p/CIP
Géhin, M., Mark, M. P., Dennefeld, C., Dierich, A., Gronemeyer, H., & Chambon, P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.16.5923-5937.2002 · Cited by 267
Hamm, J. K., Park, B. H., & Farmer, S. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100797200 · Cited by 260
PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease
Corona, J. C., & Duchen, M. R. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.06.023 · Cited by 271
Han, L., Shen, W., Bittner, S., Kraemer, F. B., & Azhar, S. (2017) · Future Cardiology · doi:10.2217/fca-2017-0019 · Cited by 266
Mechanisms Mediating the Regulation of Peroxisomal Fatty Acid Beta-Oxidation by PPARα
Tahri-Joutey, M., Andreoletti, P., Surapureddi, S., Nasser, B., Cherkaoui‐Malki, M., & Latruffe, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168969 · Cited by 273
Excitation‐transcription coupling in skeletal muscle: the molecular pathways of exercise
Gundersen, K. (2010) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.2010.00161.x · Cited by 281
PPAR Agonists and Metabolic Syndrome: An Established Role?
Botta, M., Audano, M., Sahebkar, A., Sirtori, C. R., Mitro, N., & Ruscica, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041197 · Cited by 260
PPARs and ERRs: molecular mediators of mitochondrial metabolism
Fan, W., & Evans, R. M. (2014) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.11.002 · Cited by 266
ADIPOCYTE DIFFERENTIATION AND LEPTIN EXPRESSION
Hwang, C.-S., Loftus, T. M., Mandrup, S., & Lane, M. D. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.231 · Cited by 249
Peroxisome proliferator-activated receptor-α and liver cancer: where do we stand?
Peters, J. M., Cheung, C., & Gonzalez, F. J. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0678-9 · Cited by 249
Rajaram, M. V. S., Brooks, M. N., Morris, J. D., Torrelles, J. B., Azad, A. K., & Schlesinger, L. S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000866 · Cited by 256
Activation of PPARγ inhibits cell growth and induces apoptosis in human gastric cancer cells
Takahashi, N., Okumura, T., Motomura, W., Fujimoto, Y., Kawabata, I., & Kohgo, Y. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00871-6 · Cited by 245
Schmuth, M., Haqq, C. M., Cairns, W. J., Holder, J. C., Dorsam, S. T., Chang, S., Lau, P., Fowler, A. J., Chuang, G. S., Moser, A. H., et al. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22412.x · Cited by 244
Do Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Hazard to Humans?
Cattley, R. C., DeLuca, J. G., Elcombe, C. R., Fenner-Crisp, P. A., Lake, B. G., Marsman, D. S., Pastoor, T. A., Popp, J. A., Robinson, D. E., Schwetz, B. A., et al. (1998) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1997.1163 · Cited by 244
Self-citationLocalization of PPAR isotypes in the adult mouse and human brain
Warden, A. S., Truitt, J., Merriman, M., Ponomareva, O. Y., Jameson, K. G., Ferguson, L. B., Mayfield, R. D., & Harris, R. A. (2016) · Scientific Reports · doi:10.1038/srep27618 · Cited by 243
PPAR-α–Null Mice Are Protected From High-Fat Diet–Induced Insulin Resistance
Guerre-Millo, M., Rouault, C., Poulain, P., André, J., Poitout, V., Peters, J. M., Gonzalez, F. J., Fruchart, J.-C., Reach, G., & Staels, B. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2809 · Cited by 241
The PPAR trio: Regulators of myocardial energy metabolism in health and disease
Madrazo, J., & Kelly, D. P. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.03.021 · Cited by 247
Preiss-Landl, K., Zimmermann, R., Hämmerle, G., & Zechner, R. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200210000-00002 · Cited by 246
PPAR-α as a Key Nutritional and Environmental Sensor for Metabolic Adaptation
Contreras, A. V., Torres, N., & Tovar, A. R. (2013) · Advances in Nutrition · doi:10.3945/an.113.003798 · Cited by 244
Latruffe, N., & Vamecq, J. (1997) · Biochimie · doi:10.1016/s0300-9084(97)81496-4 · Cited by 235
LSDP5 is a PAT protein specifically expressed in fatty acid oxidizing tissues
Dalen, K. T., Dahl, T. B., Holter, E., Arntsen, B. M., Londos, C., Sztalryd, C., & Nebb, H. I. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.11.011 · Cited by 244
Neschen, S., Morino, K., Dong, J., Wang-Fischer, Y., Cline, G. W., Romanelli, A. J., Rossbacher, J. C., Moore, I. K., Regittnig, W., Muñoz, D. S., et al. (2007) · Diabetes · doi:10.2337/db06-1206 · Cited by 236
Peroxisome proliferator-activated receptor gamma (PPARγ) and its ligands: A review
Houseknecht, K. L., Cole, B. M., & Steele, P. J. (2002) · Domestic Animal Endocrinology · doi:10.1016/s0739-7240(01)00117-5 · Cited by 240
Pineda‐Torra, I., Gervois, P. P., & Staels, B. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199904000-00009 · Cited by 232
Shu, H., Wong, B., Zhou, G., Li, Y., Berger, J., Woods, J. W., Wright, S. D., & Cai, T. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1968 · Cited by 231
PPARα deficiency reduces insulin resistance and atherosclerosis in apoE-null mice
Tordjman, K. M., Bernal‐Mizrachi, C., Zemany, L., Weng, S., Chu, F., Zhang, F., Leone, T. C., Coleman, T., Kelly, D. P., & Semenkovich, C. F. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11497 · Cited by 228
Modulation of immune function by dietary fatty acids
Miles, E. A., & Calder, P. C. (1998) · Proceedings of The Nutrition Society · doi:10.1079/pns19980042 · Cited by 230
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx073 · Cited by 226
Muoio, D. M., Way, J. M., Tanner, C. J., Winegar, D. A., Kliewer, S. A., Houmard, J. A., Kraus, W. E., & Dohm, G. L. (2002) · Diabetes · doi:10.2337/diabetes.51.4.901 · Cited by 226
Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans
Guan, Y., Zhang, Y., Davis, L. S., & Breyer, M. D. (1997) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1997.273.6.f1013 · Cited by 223
Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis
Yeldandi, A. V., Rao, M. S., & Reddy, J. K. (2000) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(99)00234-1 · Cited by 228
Gosset, P., Charbonnier, A.-S., Delerive, P., Fontaine, J., Staels, B., Pestel, J., Tonnel, A., & Trottein, F. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10 · Cited by 225
The Acute Phase Response Is Associated with Retinoid X Receptor Repression in Rodent Liver
Beigneux, A. P., Moser, A. H., Shigenaga, J. K., Grunfeld, C., & Feingold, K. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000953200 · Cited by 223
PPARs Integrate the Mammalian Clock and Energy Metabolism
Chen, L., & Yang, G. (2014) · PPAR Research · doi:10.1155/2014/653017 · Cited by 229
Chatterjee, P. K. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0183-5 · Cited by 221
Komar, C. M. (2005) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-3-41 · Cited by 229
Acute renal failure. I. Relative importance of proximal vs. distal tubular injury
Lieberthal, W., & Nigám, S. K. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.275.5.f623 · Cited by 220
Review of the Structural and Dynamic Mechanisms of PPAR γ Partial Agonism
Kroker, A. J., & Bruning, J. B. (2015) · PPAR Research · doi:10.1155/2015/816856 · Cited by 231
Chen, Y., Tang, Y., Guo, C., Wang, J., Boral, D., & Nie, D. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.030 · Cited by 227
PPARγ-mediated insulin sensitization: the importance of fat versus muscle
Kintscher, U., & Law, R. E. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00440.2004 · Cited by 222
Abbott, B. D. (2008) · Reproductive Toxicology · doi:10.1016/j.reprotox.2008.10.001 · Cited by 217
Peroxisome Proliferator-Activated Receptors, Coactivators, and Downstream Targets
Qi, C., Zhu, Y., & Reddy, J. K. (2000) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:32:1-3:187 · Cited by 220
Ohta, T., Masutomi, N., Tsutsui, N., Sakairi, T., Mitchell, M., Milburn, M. V., Ryals, J. A., Beebe, K. D., & Guo, L. (2009) · Toxicologic Pathology · doi:10.1177/0192623309336152 · Cited by 213
Jack, A. K. E., Hamm, J. K., Pilch, P. F., & Farmer, S. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7946 · Cited by 215
Ehrenborg, E., & Krook, A. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001560 · Cited by 222
Froment, P., Gizard, F., Defever, D., Staels, B., Dupont, J., & Monget, P. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06667 · Cited by 218
Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis
Neve, B., Fruchart, J., & Staels, B. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00430-5 · Cited by 211
Diascro, D. D., Vogel, R. L., Johnson, T. E., Witherup, K. M., Pitzenberger, S. M., Rutledge, S. J., Prescott, D. J., Rodan, G. A., & Schmidt, A. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.1.96 · Cited by 211
Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage
YI, J., PARK, S., KAPADIA, R., & VEMUGANTI, R. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.04.019 · Cited by 206
Beneficial effects of PPAR-? ligands in ischemia?reperfusion injury, inflammation and shock
Abdelrahman, M. S. I., Sivarajah, A., & Thiemermann, C. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.12.008 · Cited by 206
Schmuth, M., Jiang, Y. J., Dubrac, S., Elias, P. M., & Feingold, K. R. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800001-jlr200 · Cited by 204
Erkekoğlu, P., Rachidi, W., Gürsoy-Yüzügüllü, Ö., Giray, B., Favier, A. E., Öztürk, M., & Hıncal, F. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.07.016 · Cited by 207
Holden, P. R., & Tugwood, J. D. (1999) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0220001 · Cited by 200
Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions
Michalik, L., & Wahli, W. (1999) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)00030-0 · Cited by 200
Self-citationPPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Park, C. W., Zhang, Y., Zhang, X., Wu, J., Chen, L., Cha, D. R., Su, D., Hwang, M.-T., Fan, X., Davis, L., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5000209 · Cited by 202
Xu, Y., Romero, R. J., Miller, D., Kadam, L., Mial, T. N., Plazyo, O., Garcia‐Flores, V., Hassan, S. S., Xu, Z., Tarca, A. L., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502055 · Cited by 202
Metadata
- Authors
- Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W.
- Affiliations
- University of Lausanne (CH)
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1996-01
- Volume
- 137
- Issue
- 1
- Pages
- 354-366
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2047982128
- Cited by
- 2,217
- References
- 0
- Citations by year
- 2026: 14 · 2025: 34 · 2024: 31 · 2023: 32 · 2022: 56 · 2021: 53 · 2020: 50 · 2019: 42 · 2018: 74 · 2017: 64 · 2016: 76 · 2015: 65 · 2014: 75 · 2013: 95 · 2012: 71
- FWCI
- 23.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- peroxisome proliferator-activated receptors, PPARα, PPAR-beta, PPARγ, tissue distribution, nuclear receptors, lipid metabolism, adipogenesis, hepatocytes, cardiomyocytes, enterocytes, proximal tubular epithelial cells, adipose tissue, immune system, rats
- MeSH terms
- Animals, Base Sequence, Female, Male, Molecular Sequence Data, Tissue Distribution, Transcription Factors, Molecular Probes, Rats, Sprague-Dawley, In Situ Hybridization, Receptors, Cytoplasmic and Nuclear, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review